BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2572135)

  • 1. Reversal of profound paralysis: use of large doses of edrophonium to antagonize vecuronium and pancuronium induced neuromuscular blockade.
    Power SJ; Jones RM
    Acta Anaesthesiol Scand; 1989 Aug; 33(6):478-81. PubMed ID: 2572135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edrophonium antagonism of pancuronium-induced neuromuscular blockade in man: a reappraisal.
    Kopman AF
    Anesthesiology; 1979 Aug; 51(2):139-42. PubMed ID: 453615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edrophonium antagonism of vecuronium at varying degrees of fourth twitch recovery.
    Salib YM; Donati F; Bevan DR
    Can J Anaesth; 1993 Sep; 40(9):839-43. PubMed ID: 8104729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M; Vilardi V; Fierro G; Rosa G; Pelaia P; Gasparetto A
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine.
    Donati F; McCarroll SM; Antzaka C; McCready D; Bevan DR
    Anesthesiology; 1987 Apr; 66(4):471-6. PubMed ID: 3565812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-responses for edrophonium during antagonism of vecuronium block in young and older adult patients.
    McCarthy GJ; Mirakhur RK; Maddineni VR; McCoy EP
    Anaesthesia; 1995 Jun; 50(6):503-6. PubMed ID: 7618662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tactile evaluation of train-of-four count as an indicator of reliability of antagonism of vecuronium- or atracurium-induced neuromuscular blockade.
    Kopman AF
    Anesthesiology; 1991 Oct; 75(4):588-93. PubMed ID: 1681762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.
    Beattie WS; Buckley DN; Forrest JB
    Can J Anaesth; 1992 Nov; 39(9):925-31. PubMed ID: 1360337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edrophonium as an antagonist of vecuronium-induced neuromuscular block in the elderly.
    Kitajima T; Ishii K; Ogata H
    Anaesthesia; 1995 Apr; 50(4):359-61. PubMed ID: 7747859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of pancuronium with edrophonium.
    Bevan DR
    Anaesthesia; 1979; 34(7):614-9. PubMed ID: 229740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edrophonium and neostigmine for reversal of the neuromuscular blocking effect of vecuronium.
    Engbaek J; Ording H; Ostergaard D; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jul; 29(5):544-6. PubMed ID: 2863917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low and high frequency stimulation tests to characterize the effects of edrophonium on vecuronium-induced neuromuscular block.
    Baurain MJ; Dernovoi BS; d'Hollander AA; Hennart DA; Cantraine FR
    Br J Anaesth; 1995 Jan; 74(1):12-5. PubMed ID: 7880697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine.
    Shorten GD; Ali HH; Goudsouzian NG
    Br J Anaesth; 1993 Feb; 70(2):160-2. PubMed ID: 8435259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method of intraoperative monitoring of neuromuscular function and residual blockade in the recovery room.
    Jones KA; Lennon RL; Hosking MP
    Minn Med; 1992 Jul; 75(7):23-6. PubMed ID: 1357537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neostigmine, pyridostigmine, and edrophonium as antagonists of pancuronium.
    Ferguson A; Egerszegi P; Bevan DR
    Anesthesiology; 1980 Nov; 53(5):390-4. PubMed ID: 7425377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of pancuronium- and pipecuronium-induced neuromuscular block.
    Gyermek L; Cantley EM; Lee C
    Br J Anaesth; 1995 Apr; 74(4):410-4. PubMed ID: 7734260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.